Table 2.
Exposure | Outcome | SNPs | Method | OR (95% CI) | P | PQ | PInt | PG | Power (%) |
---|---|---|---|---|---|---|---|---|---|
HannumAge | PACG | 41 | IVW | 0.92 (0.86 to 0.99) | 0.035 | 0.510 | 0.020 | 0.502 | 65.0 |
MR-Egger | 0.75 (0.62 to 0.90) | 0.004 | |||||||
MR-PRESSO | 0.92 (0.86 to 0.99) | 0.039 | |||||||
WM | 0.90 (0.81 to 1.01) | 0.068 | |||||||
IEAA | POAG | 54 | IVW | 1.04 (1.02 to 1.06) | 6.1E-04 | 0.732 | 0.300 | 0.743 | 96.5 |
MR-Egger | 1.02 (0.97 to 1.06) | 0.521 | |||||||
MR-PRESSO | 1.04 (1.02 to 1.06) | 5.7E-04 | |||||||
WM | 1.03 (0.996 to 1.060) | 0.084 | |||||||
PAI-1 | AMD | 33 | IVW | 1.00006 (1.000002 to 1.0001) | 0.042 | 0.291 | 0.510 | 0.335 | 69.3 |
MR-Egger | 1.00007 (1.000005 to 1.0001) | 0.042 | |||||||
MR-PRESSO | 1.00006 (1.000002 to 1.0001) | 0.050 | |||||||
WM | 1.00004 (0.999959 to 1.0001) | 0.320 | |||||||
GCP | Presbyopia | 27 | IVW | 0.010 (0.0002 to 0.522) | 0.022 | 0.313 | 0.211 | 0.341 | 70.6 |
MR-Egger | 0.00003 (1.69E-09 to 0.494) | 0.046 | |||||||
MR-PRESSO | 0.010 (0.0002 to 0.522) | 0.031 | |||||||
WM | 0.003 (0.00001 to 0.603) | 0.032 | |||||||
GCP | RRD | 29 | IVW | 26.64 (2.70 to 263.05) | 0.005 | 0.564 | 0.617 | 0.613 | 82.9 |
MR-Egger | 6.70 (0.02 to 2256.62) | 0.527 | |||||||
MR-PRESSO | 26.64 (2.91 to 243.72) | 0.007 | |||||||
WM | 22.27 (0.83 to 598.38) | 0.065 | |||||||
ARC | HannumAge | 31 | IVW | 0.83 (0.69 to 0.99) | 0.041 | 0.988 | 0.708 | 0.988 | 100 |
MR-Egger | 0.75 (0.45 to 1.26) | 0.289 | |||||||
MR-PRESSO | 0.83 (0.72 to 0.94) | 0.008 | |||||||
WM | 0.86 (0.66 to 1.12) | 0.259 |
AMD, age-related macular degeneration; PACG, primary angle-closure glaucoma; POAG, primary open-angle glaucoma; RRD, rhegmatogenous retinal detachment; ARC, age-related cataract; PAI-1, DNAm-based plasminogen activator inhibitor-1 levels; GCP, DNAm-based granulocyte proportions; IEAA, intrinsic epigenetic age acceleration; TSMR, two-sample Mendelian randomization; IVW, inverse-variance weighted; MR-PRESSO, Mendelian randomization pleiotropy residual sum and outlier; WM, weighted median; OR, odds ratio; 95% CI, 95% confidence interval; PQ was the P value derived from Cochran’s Q test using IVW method. PInt was the P value derived from MR-Egger intercept. PG was the P value derived from MR-PRESSO global test. P < 0.05 was considered as statistically significant